All that glitters is not gold: The need for economic evaluation of supplies' options

The system for the provision of supplies in the UK National Health Service is being continually ‘redisorganised’ in an effort to improve efficiency and get better value for money. Alongside these reorganisations, the regulation of the supply of pharmaceuticals to the NHS is also being altered. What are the differences between these two processes and can any obvious lessons be learnt from the ways in which the NHS seeks to control the prices, qualities and quantities of products in these two closely related areas of supplies?